Page last updated: 2024-11-03

risperidone and Morgellon's

risperidone has been researched along with Morgellon's in 2 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Morgellons disease is a disfiguring and distressing condition."2.58Morgellons disease: insights into treatment. ( Aung-Din, D; Feldman, SR; Jorizzo, JL; Sahni, DR, 2018)
"The condition has been referred to as Morgellons disease."1.48Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes. ( Bewley, A; Mohandas, P; Taylor, R, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mohandas, P1
Bewley, A1
Taylor, R1
Aung-Din, D1
Sahni, DR1
Jorizzo, JL1
Feldman, SR1

Reviews

1 review available for risperidone and Morgellon's

ArticleYear
Morgellons disease: insights into treatment.
    Dermatology online journal, 2018, Nov-15, Volume: 24, Issue:11

    Topics: Anti-Bacterial Agents; Antipsychotic Agents; Humans; Medication Adherence; Morgellons Disease; Physi

2018

Other Studies

1 other study available for risperidone and Morgellon's

ArticleYear
Morgellons disease: experiences of an integrated multidisciplinary dermatology team to achieve positive outcomes.
    The Journal of dermatological treatment, 2018, Volume: 29, Issue:2

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Antipsychotic

2018